Cadence
AI enabled chronic care management for older adults: supervised AI agents monitor daily vitals from connected devices, surface risk between visits, and coordinate clinical action for patients with hypertension, type 2 diabetes, heart failure, and COPD. Operates in partnership with more than 20 health systems with an embedded medical group, and reports 55 percent of vitals alerts resolved autonomously with a 3.5 minute median response time.
Capability Axes
Supervised AI agents are the engine of a chronic care management offering that includes an embedded medical group; the AI platform and the care delivery wrapper are packaged together.
Supervised agent model with published autonomous resolution rate (55 percent of vitals alerts), 3.5 minute median response time, and clinical escalation paths.
Peer reviewed publication record cited on the vendor's own site, spanning NEJM Catalyst, the Journal of the American College of Cardiology: Advances, the Journal of Cardiac Failure, Mayo Clinic Proceedings: Innovations, Quality and Outcomes, and a Circulation abstract, covering hypertension and heart failure programs with clinical outcome and utilization results. Peer reviewed publication in cardiology journals is the top anchor for this axis. Graded on the existence and venue of the evidence; this index does not re verify the underlying studies, and the vendor's operational figures (55 percent autonomous alert resolution, 3.5 minute median response, $1,302 per patient cost reduction) remain vendor reported.
The patient terms of use state that Cadence must protect PHI in accordance with HIPAA and describe permitted uses for treatment, payment, and healthcare operations. That is a legal notice to patients rather than a vendor security disclosure to buyers. No trust center, no published BAA terms, and no security certifications were found on the vendor's site; a health system buyer must establish all of this in procurement.
Deep EMR integration claimed; no marketplace listing or integration documentation verified.
Population and conditions explicitly enumerated: older adults, home based, hypertension, type 2 diabetes, heart failure, COPD.
Announced Deployments
Publicly announced health system deployments and partnerships. This is a record of announcements, not an assessment of deployment success or scale.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
No pricing data has been verified for this vendor. Pricing information will be published here once confirmed through vendor disclosure or third-party estimation.